Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study.

van Himbergen TM, Beiser AS, Ai M, Seshadri S, Otokozawa S, Au R, Thongtang N, Wolf PA, Schaefer EJ.

Arch Neurol. 2012 May;69(5):594-600.

2.

Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.

Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA.

Arch Neurol. 2006 Nov;63(11):1545-50.

PMID:
17101822
3.

Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study.

Weinstein G, Beiser AS, Choi SH, Preis SR, Chen TC, Vorgas D, Au R, Pikula A, Wolf PA, DeStefano AL, Vasan RS, Seshadri S.

JAMA Neurol. 2014 Jan;71(1):55-61. doi: 10.1001/jamaneurol.2013.4781.

4.

Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.

Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel DP, Tocco M, D'Agostino RB, Wolf PA.

Arch Intern Med. 2003 May 12;163(9):1053-7.

PMID:
12742802
5.

Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy.

Westwood AJ, Beiser A, Decarli C, Harris TB, Chen TC, He XM, Roubenoff R, Pikula A, Au R, Braverman LE, Wolf PA, Vasan RS, Seshadri S.

Neurology. 2014 May 6;82(18):1613-9. doi: 10.1212/WNL.0000000000000382. Epub 2014 Apr 4.

6.

Depressive symptoms and risk of dementia: the Framingham Heart Study.

Saczynski JS, Beiser A, Seshadri S, Auerbach S, Wolf PA, Au R.

Neurology. 2010 Jul 6;75(1):35-41. doi: 10.1212/WNL.0b013e3181e62138.

7.

Dementia and Alzheimer disease incidence: a prospective cohort study.

Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD, van Belle G, Jolley L, Larson EB.

Arch Neurol. 2002 Nov;59(11):1737-46.

PMID:
12433261
8.

Impaired insulin secretion increases the risk of Alzheimer disease.

Rönnemaa E, Zethelius B, Sundelöf J, Sundström J, Degerman-Gunnarsson M, Berne C, Lannfelt L, Kilander L.

Neurology. 2008 Sep 30;71(14):1065-71. doi: 10.1212/01.wnl.0000310646.32212.3a. Epub 2008 Apr 9.

PMID:
18401020
9.

Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study.

Sundelöf J, Giedraitis V, Irizarry MC, Sundström J, Ingelsson E, Rönnemaa E, Arnlöv J, Gunnarsson MD, Hyman BT, Basun H, Ingelsson M, Lannfelt L, Kilander L.

Arch Neurol. 2008 Feb;65(2):256-63. doi: 10.1001/archneurol.2007.57.

PMID:
18268197
10.

Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study.

Akomolafe A, Beiser A, Meigs JB, Au R, Green RC, Farrer LA, Wolf PA, Seshadri S.

Arch Neurol. 2006 Nov;63(11):1551-5.

PMID:
17101823
11.

Low cardiac index is associated with incident dementia and Alzheimer disease: the Framingham Heart Study.

Jefferson AL, Beiser AS, Himali JJ, Seshadri S, O'Donnell CJ, Manning WJ, Wolf PA, Au R, Benjamin EJ.

Circulation. 2015 Apr 14;131(15):1333-9. doi: 10.1161/CIRCULATIONAHA.114.012438. Epub 2015 Feb 19.

12.

APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.

Huang W, Qiu C, von Strauss E, Winblad B, Fratiglioni L.

Arch Neurol. 2004 Dec;61(12):1930-4. Erratum in: Arch Neurol. 2005 Mar;62(3):453.

PMID:
15596614
13.

Insulin-like growth factor-I receptor stimulating activity is associated with dementia.

de Bruijn RF, Janssen JA, Brugts MP, van Duijn CM, Hofman A, Koudstaal PJ, Ikram MA.

J Alzheimers Dis. 2014;42(1):137-42. doi: 10.3233/JAD-140186.

PMID:
24820016
14.

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA.

N Engl J Med. 2002 Feb 14;346(7):476-83.

15.

Resistin, adiponectin, and risk of heart failure the Framingham offspring study.

Frankel DS, Vasan RS, D'Agostino RB Sr, Benjamin EJ, Levy D, Wang TJ, Meigs JB.

J Am Coll Cardiol. 2009 Mar 3;53(9):754-62. doi: 10.1016/j.jacc.2008.07.073. Epub 2008 Dec 26.

16.

Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study.

Irie F, Fitzpatrick AL, Lopez OL, Kuller LH, Peila R, Newman AB, Launer LJ.

Arch Neurol. 2008 Jan;65(1):89-93. doi: 10.1001/archneurol.2007.29.

PMID:
18195144
17.

Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease.

Gu Y, Luchsinger JA, Stern Y, Scarmeas N.

J Alzheimers Dis. 2010;22(2):483-92. doi: 10.3233/JAD-2010-100897.

18.

Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study.

Fitzpatrick AL, Irizarry MC, Cushman M, Jenny NS, Chi GC, Koro C.

Atherosclerosis. 2014 Aug;235(2):384-91. doi: 10.1016/j.atherosclerosis.2014.04.032. Epub 2014 May 22.

19.

The role of peripheral inflammatory markers in dementia and Alzheimer's disease: a meta-analysis.

Koyama A, O'Brien J, Weuve J, Blacker D, Metti AL, Yaffe K.

J Gerontol A Biol Sci Med Sci. 2013 Apr;68(4):433-40. doi: 10.1093/gerona/gls187. Epub 2012 Sep 14.

20.

Endogenous sex hormones as risk factors for dementia in elderly men and women.

Ravaglia G, Forti P, Maioli F, Bastagli L, Montesi F, Pisacane N, Chiappelli M, Licastro F, Patterson C.

J Gerontol A Biol Sci Med Sci. 2007 Sep;62(9):1035-41.

PMID:
17895444

Supplemental Content

Support Center